Lung Cancer Update cover image

Striving for Consensus on the Management of ALK-Positive Lung Cancer

Lung Cancer Update

00:00

Do You Use Lorlatanate in Brain Metastasies?

The presence of brain metastasies doesn't push me to Lorlatanib when we go through the real-life cases I tried really hard to think of one situation where I would absolutely start with Lorlatan Tib. Ben says his dose reduction rate is 50 percent as opposed to 20 percent in the trial and so you know there's more toxicity going on than was captured in that paper.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app